The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.
Somatostatin receptors: From signaling to clinical practice
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–289 of 289
de Bruin, C., Feelders, R. A., Waaijers, A. M., van Koetsveld, P. M., Sprij-Mooij, D. M., Lamberts, S. W. J., & Hofland, L. J. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0110 · Cited by 88
Somatostatin receptor subtype expression and function in human vascular tissue
Curtis, S. B., Hewitt, J., Yakubovitz, S., Anzarut, A., Hsiang, Y. N., & Buchan, A. M. J. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h1815 · Cited by 86
Afargan, M., Janson, E. T., Gelerman, G., Rosenfeld, R., Ziv, O., Karpov, O., Wolf, A., Bracha, M., Shohat, D., Liapakis, G., et al. (2001) · Endocrinology · doi:10.1210/en.142.1.477 · Cited by 85
Pritchard, K. I., Shepherd, L. E., Chapman, J. W., Norris, B. D., Cantin, J., Goss, P. E., Dent, S. F., Walde, D., Vandenberg, T. A., Findlay, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7006 · Cited by 85
Ren, S.-G., Kim, S., Taylor, J., Dong, J., Moreau, J.-P., Culler, M. D., & Melmed, S. K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030302 · Cited by 85
Dopamine Receptor Expression and Function in Human Normal Adrenal Gland and Adrenal Tumors
Pivonello, R., Ferone, D., de Herder, W. W., de Krijger, R. R., Waaijers, M., Mooij, D. M., van Koetsveld, P. M., Barreca, A., De, M. D. B., Lombardi, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031746 · Cited by 84
Weckbecker, G., Tolcsvai, L., Stolz, B., Pollak, M., & Bruns, C. (1994) · PubMed · Cited by 83
Redfern, J. S., & Fortuner, W. J. (1995) · PubMed · Cited by 83
Somatostatin Receptor Subtype 4 Couples to the M-Current to Regulate Seizures
Qiu, C., Zeyda, T., Johnson, B. N., Hochgeschwender, U., de Lecea, L., & Tallent, M. K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4679-07.2008 · Cited by 83
Meisetschläger, G., Poethko, T., Stahl, A. R., Wolf, I., Scheidhauer, K., Schottelius, M., Herz, M., Wester, H. J., & Schwaiger, M. (2006) · PubMed · Cited by 83
Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zone
Aguilera, G., Harwood, J. P., & Catt, K. J. (1981) · Nature · doi:10.1038/292262a0 · Cited by 82
Janson, E., Stridsberg, M., Gobl, A., Westlin, J.-E., & Öberg, K. (1998) · PubMed · Cited by 81
Fjällskog, M.-L., Sundin, A., Westlin, J. E., Öberg, K., Janson, E. T., & Eriksson, B. K. (2002) · Medical Oncology · doi:10.1385/mo:19:1:35 · Cited by 80
Florio, T., Thellung, S., Arena, S. K., Corsaro, A., Spaziante, R., Gussoni, G., Acuto, G., Giusti, M., Giordano, G., & Schettini, G. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410396 · Cited by 80
The Novel Somatostatin Ligand (SOM230) Regulates Human and Rat Anterior Pituitary Hormone Secretion
Murray, R. D., Kim, K., Ren, S.-G., Lewis, I., Weckbecker, G., Bruns, C., & Melmed, S. K. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031319 · Cited by 79
Colao, A. A. L., Pivonello, R., Rosato, F., Tita, P., Menis, E. D., Barreca, A., Ferrara, R., Mainini, F., Arosio, M., & Lombardi, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02467.x · Cited by 79
Effect of octreotide on glucose tolerance in acromegaly
Koop, B. L., Harris, A. G., & Ezzat, S. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300581 · Cited by 79
Renner, U., Arzberger, T., Pagotto, U., Leimgruber, S., Uhl, E., Müller, A., Lange, M., Weindl, A., & Stalla, G. K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4685 · Cited by 77
Self-citationReisine, T., & Axelrod, J. (1983) · Endocrinology · doi:10.1210/endo-113-2-811 · Cited by 77
Somatostatin activates an inwardly rectifying K+ conductance in freshly dispersed rat somatotrophs.
Sims, S. M., Lussier, B., & Kraicer, J. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018770 · Cited by 75
Srikant, C. B., & Shen, S. H. (1996) · Endocrinology · doi:10.1210/en.137.8.3461 · Cited by 73
Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2.
Hou, C., Gilbert, R., & Barber, D. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34068-1 · Cited by 72
Strowski, M. Z., Dashkevicz, M. P., Parmar, R. M., Wilkinson, H. A., Köhler, M. G., Schaeffer, J. M., & Blake, A. D. (2002) · Neuroendocrinology · doi:10.1159/000059430 · Cited by 70
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids
Zatelli, M. C., Minoia, M., Martini, C., Tagliati, F., Ambrosio, M. R., Schiavon, M., Buratto, M., Calabrese, F., Gentilin, E., Cavallesco, G., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0097 · Cited by 70
Kvols, L. K., Brown, M. L., O’Connor, M. K., et al. (1993) · Radiology · doi:10.1148/radiology.187.1.8383865 · Cited by 70
Selvarajah, D., Webster, J., Ross, R. J. M., & Newell-Price, J. D. C. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01888 · Cited by 70
Zambre, Y., Ling, Z., Chen, M.-C., Hou, X., Woon, C.-W., Culler, M. D., Taylor, J. E., Coy, D. H., Schravendijk, C. V., Schuit, F. C., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00010-6 · Cited by 69
Somatostatin receptor imaging for neuroendocrine tumors
de Herder, W. W., Kwekkeboom, D. J., Feelders, R. A., van Aken, M. O., Lamberts, S. W. J., van der Lely, A. J., & Krenning, E. P. (2006) · Pituitary · doi:10.1007/s11102-006-0270-5 · Cited by 69
Ayuk, J., Stewart, S. E., Stewart, P. M., Sheppard, M. C., & the European Sandostatin LAR Group (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01992.x · Cited by 69
Onofri, C., Theodoropoulou, M., Losa, M., Uhl, E., Lange, M., ARZT, E. S., Stalla, G. K., & Renner, U. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06992 · Cited by 68
Self-citationBrain somatostatin: Receptor-coupled transducing mechanisms and role in cognitive functions
Schettini, G. (1991) · Pharmacological Research · doi:10.1016/s1043-6618(05)80080-5 · Cited by 67
Pasquali, D., Rossi, V., Conzo, G., Pannone, G., Bufo, P., Bellis, A. D., Renzullo, A., Bellastella, G., Colao, A., Vallone, G., et al. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0012 · Cited by 67
MA, P., WANG, Y., Vanderhoek, J. Y., NEDELMAN, J., SCHRAN, H. F., Tran, L. M., & Lamberts, S. W. J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.04.003 · Cited by 64
Somatostatin and somatostatin analogues in oncology
Parmar, H., Bogdén, A. E., Mollard, M., de Rouge, B., Phillips, R., & Lightman, S. L. (1989) · Cancer Treatment Reviews · doi:10.1016/0305-7372(89)90013-3 · Cited by 64
Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas
Bläker, M., Schmitz, M., Gocht, A., Burghardt, S., Schulz, M., Bröring, D. C., Pace, A., Greten, H., & de Weerth, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.018 · Cited by 63
Florio, T., Thellung, S., Arena, S. K., Corsaro, A., Bajetto, A., Schettini, G., & Stork, P. A. (2000) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(00)00214-x · Cited by 63
Effects of somatostatin analogs on glucose homeostasis in rats
SCHMID, H. A., & Brueggen, J. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0224 · Cited by 63
Plöckinger, U., Hoffmann, U., Geese, M., Lupp, A., Buchfelder, M., Flitsch, J., Vajkoczy, P., Jakob, W., Saeger, W., Schulz, S., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0737 · Cited by 62
EFFECTS OF SOMATOSTATIN ANALOGUE SMS 201–995 IN NORMAL MAN
DAVIES, R. R., Miller, M. A., Turner, S. J., Goodship, T. H. J., Cook, D. B., WATSON, M., McGill, A. E., Ørskov, H., Alberti, K. G. M. M., & Johnston, D. G. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb01663.x · Cited by 60
Steffin, B., Gutt, B., Bidlingmaier, M., Dieterle, C. D., Oltmann, F., & Schopohl, J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02185 · Cited by 60
Fujii, Y., Gonoi, T., Yamada, Y., Chihara, K., Inagaki, N., & Seino, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01159-1 · Cited by 59
Katznelson, L. J., Oppenheim, D. S., Coughlin, J. F., Kliman, B., Schoenfeld, D., & Klibanski, A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.5.1358910 · Cited by 59
ZAC1 target genes and pituitary tumorigenesis
Theodoropoulou, M., Stalla, G. K., & Spengler, D. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.033 · Cited by 58
Self-citationTsuzaki, S., & Moses, A. C. (1990) · Endocrinology · doi:10.1210/endo-126-6-3131 · Cited by 58
Gatto, F., Barbieri, F., Gatti, M., Würth, R., Schulz, S., Ravetti, J., Zona, G., Culler, M. D., Saveanu, A., Giusti, M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04200.x · Cited by 57
Buchan, A. M. J., Lin, C., Choi, J. C. S., & Barber, D. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201261200 · Cited by 54
Sellers, L. A., Feniuk, W., Humphrey, P. P. A., & Lauder, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16423 · Cited by 53
Douziech, N., Calvo, E. L., Coulombe, Z., Muradia, G., Bastien, J., Aubin, R. A., Lajas, A. I., & Morisset, J. (1999) · Endocrinology · doi:10.1210/endo.140.2.6492 · Cited by 52
Rossowski, W., Gu, Z. F., Akarca, U. S., Jensen, R. T., & Coy, D. H. (1994) · Peptides · doi:10.1016/0196-9781(94)90118-x · Cited by 52
Sakanaka, C., Ferby, I., Waga, I., Bito, H., & Shimizu, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2623 · Cited by 50
Córdoba‐Chacón, J., Gahete, M. D., Culler, M. D., Castano, J. P., Kineman, R. D., & Luque, R. M. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02261.x · Cited by 48
Quinn, T. J., Yuan, Z., Adem, A., Geha, R. C., Vrikshajanani, C., Koba, W. R., Fine, E. J., Hughes, D. T., SCHMID, H. A., & Libutti, S. K. (2012) · Surgery · doi:10.1016/j.surg.2012.08.021 · Cited by 48
Somatostatin analogs for the treatment of neuroendocrine tumors
Culler, M. D., Öberg, K., Arnold, R., Krenning, E. P., Sevilla, I., & Díaz, J. Á. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9293-0 · Cited by 48
Receptor Isoforms Mediate Opposing Proliferative Effects through Gβγ-Activated p38 or Akt Pathways
Sellers, L. A., Alderton, F., Carruthers, A. M., Schindler, M., & Humphrey, P. P. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5974-5985.2000 · Cited by 48
Leyton, J., Iddon, L., Perumal, M., Indrevoll, B., Glaser, M., Robins, E. G., George, A. J. T., Cuthbertson, A., Luthra, S. K., & Aboagye, E. O. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.088906 · Cited by 45
Najib, S., Saint‐Laurent, N., Estève, J., Schulz, S., Boutet-Robinet, E. A., Fourmy, D., Lättig, J., Mollereau, C., Pyronnet, S., Susini, C., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06252-11 · Cited by 44
Cholelithiasis and acromegaly: therapeutic strategies
Montini, M., Gianola, D., Paganl, M. D., Pedroncelli, A. M., Caldara, R., Gherardi, F., Bonelli, M., Lancranjan, I., & Pagani, G. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03938.x · Cited by 43
Lussier, B., WOOD, D. A., French, M. B., Moor, B. C., & Kraicer, J. (1991) · Endocrinology · doi:10.1210/endo-128-1-583 · Cited by 43
WILKINSON, G. F., Feniuk, W., & Humphrey, P. P. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701116 · Cited by 41
Fedele, M., Martino, I. D., Pivonello, R., Ciarmiello, A., De, M. D. B., Visone, R., Palmieri, D., Pierantoni, G. M., Arra, C., SCHMID, H. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2505 · Cited by 41
Öberg, K. (2012) · Endocrine · doi:10.1007/s12020-012-9681-4 · Cited by 40
Ruan, W., Fahlbusch, F. B., Clemmons, D. R., Monaco, M. E., Walden, P. D., Silva, A. P., SCHMID, H. A., & Kleinberg, D. L. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0283 · Cited by 39
Ono, K., Suzuki, T., Miki, Y., Taniyama, Y., Nakamura, Y., Noda, Y., Watanabe, M., & Sasano, H. (2007) · PubMed · Cited by 38
Kreienkamp, H., Roth, A. J. K., & Richter, D. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.869 · Cited by 37
Radiolabeled Carbohydrated Somatostatin Analogs: A Review of the Current Status
Wester, H., Schottelius, M., Poethko, T., Bruus-Jensen, K., & Schwaiger, M. (2004) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497804323072011 · Cited by 37
Verset, G., Verslype, C., Reynaert, H., Borbath, I., Langlet, P., Vandebroek, A., Peeters, M., Houbiers, G., Francque, S., Arvanitakis, M., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603901 · Cited by 37
Lin, C., Varma, M. G., Joubel, A., Madabushi, S., Lichtarge, O., & Barber, D. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212315200 · Cited by 36
Dietrich, H., Hu, K., Ruffin, M., Song, D., Bouillaud, E., Wang, Y., & Hasskarl, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0773 · Cited by 36
Simard, J., Labrie, F., & Gossard, F. (1986) · DNA · doi:10.1089/dna.1986.5.263 · Cited by 35
Azar, R., Najib, S., Lahlou, H., Susini, C., & Pyronnet, S. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8418-2 · Cited by 35
Shimon, I., Rubinek, T., Hadani, M., & Alhadef, N. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347512 · Cited by 34
Somatostatin analog octreotide LAR®in gastro–entero–pancreatic tumors
Öberg, K. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.26 · Cited by 33
Luque, R. M., Durán‐Prado, M., García‐Navarro, S., Gracia‐Navarro, F., Kineman, R. D., Malagón, M. M., & Castano, J. P. (2006) · Endocrinology · doi:10.1210/en.2005-1559 · Cited by 32
Peverelli, E., Lania, A. G., Mantovani, G., Beck‐Peccoz, P., & Spada, A. (2009) · Endocrinology · doi:10.1210/en.2008-1785 · Cited by 31
Interferon-α-2a Is a Potent Inhibitor of Hormone Secretion by Cultured Human Pituitary Adenomas
Hofland, L. J., de Herder, W. W., Waaijers, M., Zuijderwijk, J. M., Uitterlinden, P., van Koetsveld, P. M., & Lamberts, S. W. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6005 · Cited by 31
Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors
Chan, J., Ryan, D., Zhu, A., Abrams, T., Wolpin, B., Malinowski, P., Regan, E., Fuchs, C., & Kulke, M. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-11-0382 · Cited by 30
Betzel, T., Heß, T., Waser, B., Reubi, J. C., & Roesch, F. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800101h · Cited by 30
Multiple Effector Coupling of Somatostatin Receptor Subtype SSTR1
Kubota, A., Yamada, Y., Kagimoto, S., Yasuda, K., Someya, Y., Ihara, Y., Okamoto, Y., Kozasa, T., Seino, S., & Seino, Y. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2442 · Cited by 29
Shenouda, M., Maldonado, M., Wang, Y., Bouillaud, E., Hudson, M., Nesheiwat, D., & Hu, K. (2012) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31824c3eb4 · Cited by 29
Sellers, L. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24280 · Cited by 28
Cuny, T., Mohamed, A., Graillon, T., Roche, C., Defilles, C., Germanetti, A. L., Couderc, B. C., Figarella-Branger, D. F., Enjalbert, A., Barlier, A., et al. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.026 · Cited by 27
Gruszka, A., Culler, M. D., & Melmed, S. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.020 · Cited by 27
Arena, S., Pattarozzi, A., Massa, A., Estève, J., Iuliano, R., Fusco, A., Susini, C., & Florio, T. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0081 · Cited by 25
Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
Hadcock, J. R., Strnad, J., & Eppler, C. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10012-6 · Cited by 22
A Tyrosine Phosphatase is Associated with the Somatostatin Receptor
Delesque, N., Buscail, L., Estève, J. P., Rauly, I., Zeggari, M., Saint‐Laurent, N., Bell, G. I., Schally, A. V., Vaysse, N., & Susini, C. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514733.ch12 · Cited by 18
Hofland, L. J., Capello, A., Krenning, E. P., de Jong, M., & van Hagen, M. P. (2005) · PubMed · Cited by 18
Smith, P. A. (2009) · Endocrinology · doi:10.1210/en.2008-0883 · Cited by 16
Agonist-Induced Endocytosis of Rat Somatostatin Receptor 1
Roosterman, D., Kreuzer, O. J., Brune, N., Cottrell, G. S., Bunnett, N. W., Meyerhof, W., & Steinhoff, M. S. (2006) · Endocrinology · doi:10.1210/en.2006-1600 · Cited by 14
Boscaro, M., Zhang, Y., Sen, K., Maldonado, M., Schoenherr, U., & Jw, F. (2010) · The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego · doi:10.1210/endo-meetings.2010.part1.p6.p1-274 · Cited by 9
Cited by
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
A Consensus Statement on acromegaly therapeutic outcomes
Melmed, S., Bronstein, M. D., Chanson, P., Klibanski, A., Casanueva, F. F., Wass, J. A. H., Strasburger, C. J., Luger, A., Clemmons, D. R., & Giustina, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0058-5 · Cited by 561
Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy
Li, H., Kim, Y., Jung, H., Hyun, J. Y., & Shin, I. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00722c · Cited by 356
Nanoscale Self-Assembly for Therapeutic Delivery
Yadav, S., Sharma, A. K., & Kumar, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00127 · Cited by 324
Günther, T., Tulipano, G., Dournaud, P., Bousquet, C., Csaba, Z., Kreienkamp, H.-J., Lupp, A., Korbonits, M., Castaño, J. P., Wester, H.-J., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015388 · Cited by 253
Metadata
- Authors
- Theodoropoulou, M., & Stalla, G. K.
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 34
- Issue
- 3
- Pages
- 228-252
- ISSN
- 0091-3022 (ISSN-L)
- OpenAlex
- W2015321769
- Cited by
- 410
- References
- 289
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.